Evidence map›Paper›PMID 36500795›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Hexavalent Chromium Removal from Industrial Wastewater by Adsorption and Reduction onto Cationic Cellulose Nanocrystals.

Francisco de Borja Ojembarrena, Hassan Sammaraie, Cristina Campano, Angeles Blanco, Noemi Merayo, Carlos Negro

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Francisco de Borja OjembarrenaDepartment of Chemical Engineering and Materials, Complutense University of Madrid, Avda. Complutense s/n, 28040 Madrid, Spain.
Hassan SammaraieDepartment of Chemical Engineering and Materials, Complutense University of Madrid, Avda. Complutense s/n, 28040 Madrid, Spain.
Cristina CampanoDepartment of Chemical Engineering and Materials, Complutense University of Madrid, Avda. Complutense s/n, 28040 Madrid, Spain.ORCID 0000-0001-6964-0426
Angeles BlancoDepartment of Chemical Engineering and Materials, Complutense University of Madrid, Avda. Complutense s/n, 28040 Madrid, Spain.ORCID 0000-0001-6820-7698
Noemi MerayoDepartment of Mechanical, Chemical and Industrial Design Engineering, ETSIDI, Polytechnic University of Madrid, Ronda de Valencia 3, 28012 Madrid, Spain.ORCID 0000-0002-6609-4092
Carlos NegroDepartment of Chemical Engineering and Materials, Complutense University of Madrid, Avda. Complutense s/n, 28040 Madrid, Spain.ORCID 0000-0003-2895-4343

Funding

Comunidad de Madrid S2018/EMT-4459 (RE-TO-PROSOST-CM)Ministry of Economy, Industry and Competitiveness CTQ2017-85654-C2-2-R and predoctoral fellowship PRE2018-085034.
6 · The paper itself

Abstract

Cationic cellulose nanocrystals (CCNC) are lignocellulosic bio-nanomaterials that present large, specific areas rich with active surface cationic groups. This study shows the adsorption removal of hexavalent chromium (Cr(VI)) from industrial wastewaters by the CCNC. The CCNC were synthetized through periodate oxidation and Girard's reagent-T cationization. The high value of CCNCs cationic groups and anionic demand reveal probable nanocrystal-Cr(VI) attraction. Adsorption was performed with synthetic Cr(VI) water at different pH, dosage, Cr(VI) concentration and temperature. Fast removal of Cr(VI) was found while operating at pH 3 and 100 mg·L

Indexed as

adsorptioncationic cellulose nanocrystalscationization processhexavalent chromiumwastewater treatment

Identifiers

PMID36500795
PMCPMC9736468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.